A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

NCT00079105 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

175

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: mitoxantrone hydrochloride
DRUG: prednisolone
DRUG: procarbazine hydrochloride
DRUG: vinblastine sulfate

Sponsor

Newcastle-upon-Tyne Hospitals NHS Trust